A. T. Marcel Gosselink

Suggest Changes
Learn More
BACKGROUND β-Blockers have a class 1a recommendation in the treatment of patients with ST-elevation myocardial infarctions (STEMIs), as they are associated with a reduced mortality, recurrent(More)
  • 1